We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£138.44
This is the most expensive it has ever been. Walk away.
£138 today · previous high £138 · all-time low £129
CRC Press Biosimilars Development Strategies Book
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 25 days · 25 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 25 days • 3 price levels
Price Analysis
Most common price: £130 (14 days, 56.0%)
Price range: £129 - £138
Price levels: 3 different prices over 25 days
Description
Key Features
Analyzes regulatory filings for all approved biosimilars in both the US and EU markets.
Provides a deep analysis of the scientific principles used in biosimilar development.
Offers strategies to plan development on a fast track to address high market entry costs.
Explores how to reduce current time and cost requirements in the development process.
Covers changes in regulatory guidelines and stakeholder perceptions of safety and efficacy.
Product Specifications
- Brand
- CRC Press
- Format
- hardcover
- ASIN
- 1032517018
- Domain
- Amazon UK
- Release Date
- 15 July 2024
- Listed Since
- 25 January 2024
Barcode
No barcode data available
Similar Products You Might Like
Biosimilars and Interchangeable Biologics: Tactical Elements
CRC Press
Biosimilars and Interchangeable Biologics: Tactical Elements
CRC Press
Biosimilars and Interchangeable Biologics: Strategic Elements
CRC Press
Price unavailable
Biosimilars: A New Generation of Biologics
Springer
Biosimilars: A New Generation of Biologics
Springer
Biosimilarity: The FDA Perspective - Drug Approval Guide
CRC Press
Biosimilar and Interchangeable Biologics: From Cell Line to Commercial Launch, Two Volume Set
CRC Press
Biologics and Biosimilars: Drug Discovery and Clinical Applications
CRC Press
Biosimilar Drug Product Development (Drugs and the Pharmaceutical Sciences)
CRC Press
ASHP Biosimilars and Biologics - Healthcare Implementation Guide
American Society of Health-System Pharmacists
Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics
Elsevier
Biosimilar Drug Product Development - CRC Press Guide
CRC Press
Biosimilars and Interchangeable Biologics: Strategic Elements
CRC Press
Biosimilar Clinical Development: Scientific Considerations and New Methodologies (Chapman & Hall/CRC Biostatistics Series)
CRC Press
Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)
Springer
Springer Development of Biopharmaceutical Drug-Device Products
Springer
Commercialization of BioPharma Products in the USA (BW): A Practical Guide
Rxcommercial Research International, Incorporated
Oxford Pharmaceutical Economics and Policy 3rd Edition Book
Oxford University Press
Biopharmaceuticals: Challenges and Opportunities
CRC Press
Innovation and Commercialisation in the Biopharmaceutical Industry: Creating and Capturing Value
Edward Elgar Publishing
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
Springer
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
Springer
The 2023-2028 Outlook for Bioengineered Monoclonal Antibodies Protein Drugs in Japan
Mastering Strategic Marketing For Specialty Pharmaceuticals: A Hands-on Guide
World Scientific Publishing Company